Pulmonary hypertension associated with nonparenchymal restrictive lung diseases - PubMed
a day ago
- #medical research
- #pulmonary hypertension
- #restrictive lung disease
- Pulmonary hypertension (PH) associated with chronic lung diseases was reclassified in 2024 by the 7th World Symposium on PH, focusing on specific lung diseases like COPD and interstitial lung disease.
- A new subgroup, nonparenchymal restrictive lung disease, includes conditions such as hypoventilation syndromes and pneumonectomy, which are among the least studied PH subtypes.
- Management primarily focuses on treating the underlying condition, with limited data on the efficacy of pulmonary arterial hypertension treatments in this subgroup.
- The review aims to update on the condition's management, highlight PH mechanisms in nonparenchymal restrictive lung diseases, and explore the new classification's relevance and research needs.
- Conflict of interest disclosures include payments and grants from pharmaceutical companies for various authors involved in the study.